Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
ViennaLab/KRAS & NRAS/20 tests/5-620188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

ViennaLab/KRAS & NRAS/20 tests/5-620

Monoclonal antibody (mAb) therapies targeting epidermal growth factor receptor (EGFR) are used in metastatic colorectal cancer (mCRC) therapies. KRAS and NRAS StripAssays® identify the most relevant genetic variants of KRAS and NRAS genes interfering with treatment/therapy success.

KRAS & NRAS

  • Inhibiting EGFR with anti-EGFR mAbs prevents activation of the relevant signal transduction pathway. However, certain mutations in RAS genes result in permanent activation of parts of this pathway, rendering anti-EGFR therapies ineffective.
  • Prior to treatment with anti-EGFR mAbs, mCRC patients should be tested for RAS variants, as positive patients are unlikely to benefit from this kind of therapy.
  • KRAS and NRAS StripAssays® assist clinicians in the stratification of patients considered for anti-EGFR mAb therapies (i.e. cetuximab or panitumumab).

ProductREFUnit SizeIFUBrochure
KRAS XL StripAssay®5-68020 tests

PDF

PDF

NRAS XL StripAssay®5-62020 tests

PDF

PDF

新闻动态
行业前沿
技术文章
最新产品